RCC
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
RCC
Jul 24, 2024, 00:59 |
Blog
Paulo Bergerot: Our first study on Exercise Oncology for patients with RCC
Paulo Bergerot, Medical Oncologist at Oncoclínicas Group, shared a post on X: "Yeah! Our first…
Jul 18, 2024, 09:57 |
Blog
Chinmay Jani: Our project on ctDNA in RCC through Tempus database presented at KCRS24
Chinmay Jani, Clinical Fellow, Hematology and Oncology at the University of Miami, shared a post…
Jul 16, 2024, 20:13 |
Insight
Chinmay Jani: Truly honored to receive the Merit Award
Chinmay Jani, Clinical Fellow, Hematology and Oncology at University of Miami, made the following post…
Jul 15, 2024, 11:30 |
Blog
Neeraj Agarwal: Excellent talk by Michelle Hirsch on the pathology diagnosis of RCC variants
Neeraj Agarwal shared on X: "Surgical Pathology Toolbox and Technological Advances to Solve Kidney Cancer…
Jul 15, 2024, 06:31 |
Positive
Karl Semaan received the Outstanding Research Award at KCRS24
Sylvan Baca, GU oncologist and computational epigenomics enthusiast at Dana-Farber Cancer Institute, shared on X:…
Jul 14, 2024, 03:00 |
Insight
Comprehensive talk on treatment options in adjuvant RCC by Bradley McGregor
Neeraj Agarwal shared on X: "Emerging treatment options in adjuvant RCC kidney cancer setting, comprehensive…
Jul 7, 2024, 14:42 |
Blog
Sweta Agrawal: Key Takeaways from Support Group Meeting held for RCC at Patan Hospital in Lalitpur
Sweta Agrawal, Program Coordinator Nepal at The Max Foundation, made the following post on LinkedIn:…
Jul 7, 2024, 04:49 |
Insight
Harold J. Burstein: Important questions about 'getting to 2nd line therapy.'
Harold J. Burstein, Breast cancer specialist and professor at Dana Farber Cancer Institute, shared a…
Jul 6, 2024, 08:45 |
Insight
Tom Powles on RCC patients receiving ICI therapy
Tom Powles shared on X: “During the period of PD-1 inhibition availability for RCC in…
Jul 1, 2024, 23:51 |
Insight
Piotr Wysocki: Neoadjuvant therapy for renal-cell cancer patients is still in its infancy, unlike in melanoma
Piotr Wysocki recently posted on LinkedIn: "The PROSPER ECOG-ACRIN EA8143 study (published online in Lancet…
Jun 27, 2024, 02:23 |
Blog
Sarah Adly: Our Article on 'Optimizing Outcomes in Advanced Renal Cell Carcinoma'
Sarah Adly, NCODA Fellow in Oncology, made the following post on LinkedIn: .…
Jun 24, 2024, 17:45 |
Blog
The Max Foundation offers three medications for RCC
Sudha Samineni, Program Officer at The Max Foundation, shared on LinkedIn: …
Jun 24, 2024, 07:29 |
Blog
Rahul Gosain: GU Malignancy Highlights from ASCO24 with Toni Choueiri
Rahul Gosain shared a post on LinkedIn: "GU (Genitourinary) Malignancy Highlights from ASCO24 (American Society…
Jun 20, 2024, 14:10 |
Insight
Enrique Grande: Epigenomic signatures of sarcomatoid differentiation of RCC
Enrique Grande shared a post on X: "On Cell Reports - Epigenomic signatures of sarcomatoid…
Jun 4, 2024, 09:20 |
Insight
Marc Eid: Come check Poster Board 224 by Talal El Zarif and Karl Semaan at ASCO24
Marc Eid, Postdoctoral research fellow in Medical Oncology at the Dana-Farber Cancer Institute, shared on…
Jun 3, 2024, 15:09 |
Insight
Avelumab + Axitinib Did Not Improve Overall Survival in Patients with Metastatic Renal Cell Carcinoma: Don't Panic!
"Final overall survival (OS) and progression-free survival (PFS) results for patients with metastatic clear cell…
May 28, 2024, 14:33 |
Societies
Tom Powles: Final results for axitinib/avelumab in 1st line RCC at ASCO24
Tom Powles, Director of Barts Cancer Center, shared on X: "Final results for axitinib/avelumab in 1st…
May 28, 2024, 07:49 |
Insight
Tom Powles: Renal cancer highlights at ASCO24 - KIM1 biomarker data stands out
Toni Choueiri shared a post by Tom Powles, Director of Barts Cancer Center, on X and…
May 23, 2024, 00:35 |
Drugs
Toni Choueiri: The story of adaptive IO therapy in RCC
Toni Choueiri recently shared a post by Rana McKay, an Associate Professor of Medicine at…
May 17, 2024, 17:18 |
Cancer Types
Renal Cell Carcinoma in Children: What patients and caregivers should know about
What is Renal Cell Carcinoma? Renal cell carcinoma (RCC) is a rare type of kidney…
May 12, 2024, 07:40 |
Insight
Yüksel Ürün: Excellent research on plasma Kidney Injury Molecule-1
Yüksel Ürün shared on X: "Congratulations to Wenxin Xu and the team for their excellent…
Apr 30, 2024, 11:10 |
Blog
Mohammad Jad Moussa: Proud of Stefan Maksimović, finalist for tripartite 'Lawrence Family Bone Disease Prog of Texas' Awards
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared on…
Apr 26, 2024, 19:38 |
Opinion
Pedro C Barata: Our work on transcriptomic profiles in RCC
Pedro C Barata, Medical Oncologist at University Hospitals Seidman Cancer Center, posted on X/Twitter: "Happy…
Apr 23, 2024, 16:11 |
Blog
Laura Bukavina: Congrats on the award for top poster at IKCSEU24
Laura Bukavina, Assistant Professor of Urologic Oncology at Case Western Reserve University, shared on X:…
Apr 22, 2024, 15:26 |
Blog
Olubukola Ayodele: Attending the IKCS Europe 2024 conference in the picturesque seaside town of Sitges
Olubukola Ayodele, Consultant Medical Oncologist at Leicester Cancer Research Centre, shared on LinkedIn: "I'm currently attending…
Apr 20, 2024, 06:03 |
Insight
Toni Choueiri: The long-awaited OS results from KEYNOTE-564 are out at the New England Journal of Medicine!
Toni Choueiri shared on X/Twitter: "The long-awaited OS results from KEYNOTE-564 are out at the New…
Apr 16, 2024, 13:08 |
Blog
Shilpa Gupta: Great to have Yousef Zakharia, UI Holden Comprehensive Cancer Center talk about updates in kidney cancer
Shilpa Gupta, Director of Genitourinary Oncology at Cleveland Clinic, shared a post on X/Twitter: ''Great…
Apr 14, 2024, 03:52 |
Drugs
Piotr Wysocki: CLEAR trial – another study demonstrating that Immunotherapy and TKI combination should not be routinely recommended to favorable-risk RCC patients
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Apr 8, 2024, 22:02 |
Insight
Renee Maria Saliby: Our paper 'Impact of RCC molecular subtypes on immunotherapy and targeted therapy outcomes' is now published in Cancer Cell
Renee Maria Saliby, Postdoctoral GU Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Mar 25, 2024, 16:15 |
Insight
Piotr Wysocki: Stereotactic ablative body radiotherapy of primary tumor is highly active in patients with localized renal cell cancer
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
Jan 27, 2024, 17:17 |
Societies
ASCO GU 2024 – New insights in clear cell renal cancer (RCC) – Adjuvant perspectives
By Marcos Franca During the morning in ASCO GU 2024 meeting, in San Francisco –…
Oct 24, 2023, 15:25 |
Blog
Lauren Meehan Machos: First combination therapy
Lauren Meehan Machos, Oncology Opinion Leader Liaison - Renal, Lung, Immuno-Oncology at Pfizer, recently shared…
Jul 15, 2023, 17:43 |
Drugs
Awesome talk by Dr. Rana McKay on the future perspectives of new drugs and compounds in RCC - Fabio Schutz
Awesome talk by Dr. Rana McKay on the future perspectives of new drugs and compounds…
All:
33
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube